Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830892 · ClinicalTrials.gov registry record · NA
Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03830892: Clinical Trial NA study, sponsored by Virginia Commonwealth University.
NCT03830892 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03830892, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.
Primary Outcome
The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session. Each DPT will be completed once per study session (either 90 minutes or approximately 180 minutes into the session, timing varies based on task order presentation and potentially choices made in tasks presented prior to this task).
Interventions
- OTHER E-cigarette Lab Session 15 watts, 10 mg nicotine
- OTHER E-cigarette Lab Session 15 watts, 30 mg nicotine
- OTHER E-cigarette Lab Session 30 watts, 10 mg nicotine
- OTHER E-cigarette Lab Session 30 watts, 30 mg nicotine
- OTHER Own Brand Session - E-cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-01-18 |
| Est. Completion | 2020-03-06 |
| Phase | NA |
Why NCT03830892 stopped before completion
NCT03830892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which E-cigarette Lab Session 15 watts, 10 mg nicotine is the first listed.
NCT03830892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03830892 about?
NCT03830892 is a clinical study titled "Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers". This study aims to understand the effects of device power and nicotine concentration on the likelihood that someone would use or abuse e-cigarettes.
What is the current status of trial NCT03830892?
This trial is currently terminated. It is a NA study. The enrollment target is 48 participants. The study started on 2019-01-18. Estimated completion is 2020-03-06.
What interventions are being tested in trial NCT03830892?
The interventions under investigation include: E-cigarette Lab Session 15 watts, 10 mg nicotine (OTHER), E-cigarette Lab Session 15 watts, 30 mg nicotine (OTHER), E-cigarette Lab Session 30 watts, 10 mg nicotine (OTHER), E-cigarette Lab Session 30 watts, 30 mg nicotine (OTHER), Own Brand Session - E-cigarette (OTHER).
Who is sponsoring clinical trial NCT03830892?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03830892's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI